Baxter International stock heads into the open after a 24.5 percent year-to-date gain

At the close on September 11, 2026, Baxter International stock finished at USD 23.80 on the NYSE, up 24.5 percent since the start of 2026. Trading came with a narrow intraday range as the S&P 500 slipped 0.8 percent over the week.

Baxter International stock closed at USD 23.80 on the NYSE on September 11, 2026, marking a 24.5 percent gain since the start of 2026. The shares moved within a relatively tight intraday range while broader United States equity benchmarks lost ground over the week.

September 11, 2026 in numbers

Baxter International Inc. (ISIN US0673431090, NYSE: BAX) closed the last completed session at USD 23.80 on September 11, 2026, according to a corporate-news summary that tied the price to that date and venue. The same summary stated that this closing level left the stock 24.5 percent higher than at the beginning of 2026, underlining a notable year-to-date recovery despite recent volatility in the wider market. The intraday data around the close indicated that Baxter International shares traded in a narrow band on September 11, 2026, with the day’s low and high prices bracketing the USD 23.80 finish and confirming that the close sat comfortably within the session range. Trading volume on the NYSE in that session was consistent with the stock’s recent averages, suggesting ongoing investor interest without an exceptional surge in activity.

While Baxter International stock advanced year-to-date, the broader S&P 500 index fell 0.8 percent over the holiday-shortened week between September 4 and September 11, 2026, as rising oil prices and higher interest rates weighed on risk appetite. As TradeStation reported on September 14, 2026, the S&P 500 declined 0.8 percent over that week, framing Baxter International’s positive year-to-date performance against a more challenging backdrop for the overall United States equity market.

Today’s focus for Baxter International stock

Looking ahead to today’s United States session on September 15, 2026, Baxter International stock trades without a newly reported company-specific catalyst early in the day, and investors remain attentive to the ongoing macro environment that has recently pressured broad indexes. As CNBC noted on September 14, 2026, market participants are watching rising oil prices and interest rates, factors that can influence valuations across the healthcare and medical devices space by affecting funding conditions and overall risk sentiment. With Baxter International’s next quarterly earnings date not highlighted for the coming days in the latest publicly available calendars, short-term attention today is likely to remain on sector moves and index-level developments, alongside any new corporate disclosures that may emerge before or after the closing bell.